中国乙型肝炎疫苗免疫策略及接种进展  

Strategies and advances in hepatitis B vaccination in China

作　　者：唐林 许侠 周泽玫 王晓琪[1,2] 李继贞 尹遵栋[1,2] 王富珍[1,2] TANG Lin;XU Xia;ZHOU Zemei;WANG Xiaoqi;LI Jizhen;YIN Zundong;WANG Fuzhen(National Immunization Program,Chinese Center for Disease Control and Prevention,Beijing 100050,China;National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases,Chinese Center for Disease Control and Prevention,Beijing 102206,China)

机构地区：[1]中国疾病预防控制中心免疫规划中心,北京100050 [2]中国疾病预防控制中心传染病溯源预警与智能决策全国重点实验室,北京102206

出　　处：《临床肝胆病杂志》2025年第2期210-215,共6页Journal of Clinical Hepatology

基　　金：国家自然科学基金(11571272)。

摘　　要：乙型肝炎是全球重要的公共卫生问题。我国通过实施以乙型肝炎疫苗为核心的综合防控策略,在乙型肝炎防控方面取得了显著成效,但仍存在诸多问题和挑战。本文回顾了我国乙型肝炎免疫策略的发展历程,分析了不同人群的疫苗接种目标与进展,以及存在的问题及挑战,为进一步优化免疫策略和提升防控水平提供参考。Hepatitis B is a major global public health issue.Through the implementation of comprehensive prevention and control strategies centered on hepatitis B vaccination,China has achieved remarkable progress in hepatitis B prevention and control,while there are still many issues and challenges.This article reviews the development of hepatitis B vaccination strategies in China,analyzes the goal and advances in vaccination in different populations,and problems and challenges,in order to provide a reference for further optimizing vaccination strategies and improving the levels of prevention and control.

关 键 词：乙型肝炎疫苗 免疫 接种 疫苗 联合 

分 类 号：R186[医药卫生—流行病学] R512.62[医药卫生—公共卫生与预防医学]